"Fortunately a solution is now at hand weight-loss jabs. For pets? That's right. In the US a pilot study is testing GLP-1 drugs a category that includes Wegovy, Mounjaro and Ozempic on cats. Weight-loss injections for cats doesn't that seem a bit drastic? There are an estimated 54,500 diabetic cats in the UK, many of them already enduring a treatment consisting of twice-daily injections of insulin. The MEOW-1 pilot is for an injectable implant lasting six months."
"How does it work? GLP-1 drugs mimic a hormone that slows digestion and suppresses hunger. How much would the treatment cost? That remains to be seen, but the company conducting the trial is hoping to keep the price under $100 (75) per month. What? 75 a month? Are you kidding? That would represent a considerable saving for people whose pets are being prescribed, off-label, the human version of Ozempic by their vets, at human prices."
Ozempets are described as sylph-like and can live from newborn to about 18 years depending on species. Pet obesity rates are high: an estimated 60% of pets in the US are obese, and some studies suggest up to 65% of British dogs may be overweight or obese. Owners and the pet food industry are blamed for the problem. A US pilot trial named MEOW-1 is testing GLP-1 drugs such as Wegovy, Mounjaro and Ozempic for cats using an injectable implant lasting six months. GLP-1 drugs mimic a hormone that slows digestion and suppresses hunger. The company hopes to keep treatment costs under $100 (75) per month as an alternative to off-label human prescriptions.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]